COMMUNIQUÉS West-GlobeNewswire

UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
20/10/2026
In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44 In CD, duvakitug maintained high rates of endoscopic response, clinical response, and clinical [...]
Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition
20/10/2026
October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips’ cardiovascular informatics portfolio and support its evolution toward a more connected, AI- [...]
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
20/10/2026
ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release [...]
Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer
20/10/2026
Designation follows recent IND activation and builds on Orphan Drug Designation granted in 2025. NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced that the US Food and Drug Administration ( [...]
The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology
20/10/2026
Proteoforms are the primary effectors of biological function, and uniting the various technologies, applications, and institutions in one organization will greatly increase our knowledge and capabilities for proteoform- [...]
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
20/10/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on [...]
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
20/10/2026
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
Kane Biotech Signs Distribution Agreement with The Stevens Company
20/10/2026
Expands Kane Biotech’s commercial footprint and access to the revyve ® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study
20/10/2026
Executive Director of the Inova Saville Cancer Screening and Prevention Center will lead KATELYN-ERIN, Mammogen’s large prospective study evaluating its blood-based RNA assay to support breast cancer detection NEWPORT [...]
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
20/10/2026
“Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with top award in Clinical Research category Pivotal Phase 3 trial met primary [...]
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
20/10/2026
85% year-over-year scan volume growth in Q3 2026, contributing to 117% growth for the nine months ended September 30, 2026 European Spine Journal publishes peer-reviewed data supporting MRS as a potential viable [...]
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20/10/2026
Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of concept for OD-001 [...]
Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young
20/10/2026
RALEIGH, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Slate Medicines, Inc. (“Slate”), a clinical-stage biotechnology company committed to advancing innovative new therapies that may broaden the treatment paradigm and [...]
Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week 2026
20/10/2026
A single dose of ORK1 generated durable disease control in two independent inflammatory bowel disease mouse models ORK1 induced sustained myeloid reprogramming, regulating chronic inflammation This data supports further [...]
KFSH Brings Cardiac Catheterization Directly to Emergency Department to Accelerate Critical Care
20/10/2026
RIYADH, Saudi Arabia, Oct. 20, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) has established a dedicated Cardiac Catheterization Lab within the Emergency Department at its Riyadh [...]
Maxion Therapeutics Appoints Biopharma Leader Mikael Dolsten to Board of Directors
20/10/2026
Former Pfizer Chief Scientific Officer and President of Worldwide Research, Development and Medical brings deep experience translating scientific innovation into life-changing medicines for patients CAMBRIDGE, United [...]
Aqua free expands its product portfolio: New Baclyser® neo T Max offers greater capacity and efficiency
20/10/2026
Hamburg, Germany, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Hamburg, 20.10.2026 – Aqua free introduces the new Baclyser® neo T Max , the latest addition to its established Baclyser® neo range of sterile water filters. This [...]
Aqua free élargit sa gamme de produits : le nouveau Baclyser® neo T Max pour une capacité et une efficacité accrues
20/10/2026
Hamburg, Germany, 20 oct. 2026 (GLOBE NEWSWIRE) -- Hambourg, [date] – Avec le nouveau Baclyser® neo T Max , Aqua free présente la toute dernière évolution de sa gamme éprouvée de filtres stériles Baclyser® neo . Ce [...]
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
20/10/2026
Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (October 20, 2026) - Alvotech (NASDAQ: ALVO [...]

Pages